Uli Bialucha
Chief Tech/Sci/R&D Officer chez XILIO THERAPEUTICS, INC.
Profil
Uli Bialucha is currently the Chief Scientific Officer at Xilio Therapeutics, Inc. Previously, Uli held the position of Vice President-Drug Discovery at Immunitas Therapeutics, Inc. Uli completed their undergraduate degree at the University of Sussex and obtained a doctorate from University College London.
Postes actifs de Uli Bialucha
| Sociétés | Poste | Début |
|---|---|---|
| XILIO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/04/2021 |
Anciens postes connus de Uli Bialucha
| Sociétés | Poste | Fin |
|---|---|---|
Immunitas Therapeutics, Inc.
 Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Immunitas Therapeutics, Inc. provides cancer therapeutics services. The company was founded by Lea Hachigian, Kai Wucherpfennig, K. Dane Wittrup and Mario Suv? and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Formation de Uli Bialucha
| University of Sussex | Undergraduate Degree |
| University College London | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| XILIO THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Immunitas Therapeutics, Inc.
Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Immunitas Therapeutics, Inc. provides cancer therapeutics services. The company was founded by Lea Hachigian, Kai Wucherpfennig, K. Dane Wittrup and Mario Suv? and is headquartered in Cambridge, MA. | Health Technology |
